Top Clinical Trials companies in Belgium by Price to Earnings Ratio (P/E)

This ranking features the top 2 Clinical Trials companies in Belgium ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of 1.54, for February 06, 2025.

Belgium

Clinical Trials
Price to Earnings Ratio (P/E)
#
Name
Price to Earnings Ratio (P/E)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GLPG.AS

Galapagos NV

1

GLPG.AS

6.51

 Feb. 5, 2025 USD 22.74 -0.48%

Belgium
2
SEQUA.BR

Sequana Medical NV

2

SEQUA.BR

-3.44

 Feb. 5, 2025 USD 2.24 -2.03%

Belgium
Frequently Asked Questions
  • Which Clinical Trials company in Belgium has the highest Price to Earnings Ratio (P/E) ?

    The Clinical Trials company in Belgium with the highest Price to Earnings Ratio (P/E) is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at 6.51.

  • Which Clinical Trials company in Belgium has the lowest Price to Earnings Ratio (P/E) ?

    The Clinical Trials company in Belgium with the lowest Price to Earnings Ratio (P/E) is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at -3.44.

  • What are the top 10 Clinical Trials companies in Belgium by Price to Earnings Ratio (P/E) ?

    The top 10 Clinical Trials companies in Belgium by Price to Earnings Ratio (P/E) are Galapagos NV and Sequana Medical NV.

  • What are the bottom 10 Clinical Trials companies in Belgium by Price to Earnings Ratio (P/E) ?

    The bottom 10 Clinical Trials companies in Belgium by Price to Earnings Ratio (P/E) are Sequana Medical NV and Galapagos NV.

SV Wall Street